ā Back to Trial
Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC
Trial Locations
-
Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Contact: Janux Therapeutics, MD Ā· 1-858-206-8471 Ā· [email protected] (opens in new tab)

